United States· US:46708-151_b993c27f-9ada-45be-bb55-245e11564d83
Olmesartan Medoxomil and Hydrochlorothiazide
A medicinal product containing olmesartan medoxomil; hydrochlorothiazide, registered in United States by Alembic Pharmaceuticals Limited.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- OLMESARTAN MEDOXOMIL; HYDROCHLOROTHIAZIDE
- Manufacturer
- Alembic Pharmaceuticals Limited
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 10
- ndc1146708-151-08
- ndc1146708-151-10
- ndc1146708-151-30
- ndc11467081510880 TABLET in 1 CARTON (46708-151-08)
- ndc114670815110100 TABLET in 1 CARTON (46708-151-10)
- ndc11467081513030 TABLET in 1 BOTTLE (46708-151-30)
- ndc11467081519090 TABLET in 1 BOTTLE (46708-151-90)
- ndc1146708151911000 TABLET in 1 BOTTLE (46708-151-91)
- ndc1146708-151-90
- ndc1146708-151-91
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Olmesartan medoxomil; hydrochlorothiazide in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaACH-OLMESARTAN HCTZACCORD HEALTHCARE INC
- ItalyIDALAZIDEISTITUTO BIOCHIMICO NAZIONALE SAVIO S.R.L.
- CzechiaSARTEN PLUS HMenarini International Operations Luxembourg S.A., Luxembourg
- FinlandBenetor CompMenarini International Operations Luxembourg S.A.
- GermanyOlmecor HctTad Pharma Gmbh
- IrelandOlmesartan/Hydrochlorothiazide Clonmel 20 mg/12.5 mg film-coated tabletsClonmel Healthcare Ltd
- FranceALTEISDUO 20 mg/12,5 mg, comprimé pelliculéMENARINI INTERNATIONAL OPERATIONS LUXEMBOURG
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Mencord Plus, Olmeblo Hct
- Belgium · Belsar Plus, Co-Olmesartan
- Bulgaria · Olmesartan/Hctz Mylan, Ко-Олиместра
- Cyprus · Olartan-Plus, Olmesartan/Hydrochlorothiazide Tad
- Czechia · Sarten Plus H, Zeota Hct
- Germany · Olmecor Hct, Olmes Plus
- Denmark · Olmesartan Medoxomil/Hydrochlorothiazide Krka
- Estonia · Co-Olimestra, Mesar Plus
- Spain · Atolme Plus, Ixia Plus
- Finland · Olmesartan Medoxomil/Hydrochlorothiazide Krka
- France · Alteisduo, Coolmetec
- United Kingdom (Northern Ireland) · Olmesartan Medoxomil/Hydrochlorothiazide Accord Healthcare, Olmesartan Medoxomil/Hydrochlorothiazide Msn Laboratories Europe
- Greece · Co-Ipertas, Olartan-Plus
- Croatia · Co-Olimestra, Olmesartan/Hidroklorotiazid Genericon
- Hungary · Laresin Plus
- Ireland · Olmesartan/Hydrochlorothiazide Clonmel, Olmesartan/Hydrochlorothiazide Krka
- Italy · Idalazide, Olmegan
- Lithuania · Co-Olimestra, Mesar Plus
- Luxembourg · Belsar Plus, Olmesartan Plus Hct
- Latvia · Co-Olimestra, Mesar Plus
- Malta · Olmesartan Medoxomil/Hydrochlorothiazide Msn, Olmesartan/ Hydrochlorothiazide Msn
- Netherlands · Hydrochlorothiazide/ Olmesartan Medoxomil Aurobindo, Hydrochlorothiazide/Olmesartan Medoxomil Aurobindo
- Norway · Olmesartan Medoxomil/Hydrochlorothiazide Krka
- Poland · Co-Olimestra, Osaver Hct
- Portugal · Olmesartan + Hidroclorotiazida Sandoz, Olmesartan Medoxomilo + Hidroclorotiazida Alter
- Slovenia · Co-Tensiol, Olmicombi
- Slovakia · Tenzar Plus
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c2425808-dd61-4328-8b6f-5da69aa80466 GET /v1/drugs/c2425808-dd61-4328-8b6f-5da69aa80466?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "40; 25",
"substance": "OLMESARTAN MEDOXOMIL; HYDROCHLOROTHIAZIDE",
"productndc": "46708-151",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1; mg/1",
"application_number": "ANDA204233",
"marketing_category": "ANDA"
}See everything about olmesartan medoxomil; hydrochlorothiazide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.